Severity and Cost of RSV Hospitalization Among US Preterm Infants Following the 2014 American Academy of Pediatrics Policy Change

Leonard R. Krilov, Michael L. Forbes, Mitchell Goldstein, Rajan Wadhawan, Dan L. Stewart

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)27-34
Number of pages8
JournalInfectious Diseases and Therapy
Volume10
DOIs
StatePublished - Mar 2021

ASJC Scopus Subject Areas

  • Microbiology (medical)
  • Infectious Diseases

Keywords

  • American Academy of Pediatrics
  • Cost
  • High-risk preterm infants
  • Immunoprophylaxis
  • National Perinatal Association
  • Palivizumab
  • RSV hospitalization
  • RSV morbidity
  • Respiratory syncytial virus
  • Severity

Cite this